Rekha Rao, PhD | Authors

Articles

The Need for Novel Therapies in Mantle Cell Lymphoma

August 29, 2017

Rekha Rao, PhD, assistant professor, University of Kansas Medical Center, discusses the need to develop novel therapies in mantle cell lymphoma, including a study that explored the synergistic activity of p97 inhibitors with histone deacetylase 6 inhibitors.

Targeting Mantle Cell Lymphoma With P97 Inhibitors

May 26, 2017

Rekha Rao, PhD, assistant professor, University of Kansas Medical Center, discusses a study of the synergistic activity of p97 inhibitors with histone deacetylase 6 inhibitors in mantle cell lymphoma (MCL).